361 related articles for article (PubMed ID: 23622849)
1. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
[TBL] [Abstract][Full Text] [Related]
2. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
Brent D; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller M; Vitiello B; Ritz L; Iyengar S; Abebe K; Birmaher B; Ryan N; Kennard B; Hughes C; DeBar L; McCracken J; Strober M; Suddath R; Spirito A; Leonard H; Melhem N; Porta G; Onorato M; Zelazny J
JAMA; 2008 Feb; 299(8):901-913. PubMed ID: 18314433
[TBL] [Abstract][Full Text] [Related]
3. The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
Rengasamy M; Mansoor BM; Hilton R; Porta G; He J; Emslie GJ; Mayes T; Clarke GN; Wagner KD; Keller MB; Ryan ND; Birmaher B; Shamseddeen W; Asarnow JR; Brent DA
J Am Acad Child Adolesc Psychiatry; 2013 Apr; 52(4):370-7. PubMed ID: 23582868
[TBL] [Abstract][Full Text] [Related]
4. Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.
Shamseddeen W; Clarke G; Wagner KD; Ryan ND; Birmaher B; Emslie G; Asarnow JR; Porta G; Mayes T; Keller MB; Brent DA
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1140-8. PubMed ID: 22024002
[TBL] [Abstract][Full Text] [Related]
5. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
Shamseddeen W; Clarke G; Keller MB; Wagner KD; Birmaher B; Emslie GJ; Ryan N; Asarnow JR; Porta G; Brent DA
J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):29-36. PubMed ID: 22251024
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
Emslie GJ; Mayes T; Porta G; Vitiello B; Clarke G; Wagner KD; Asarnow JR; Spirito A; Birmaher B; Ryan N; Kennard B; DeBar L; McCracken J; Strober M; Onorato M; Zelazny J; Keller M; Iyengar S; Brent D
Am J Psychiatry; 2010 Jul; 167(7):782-91. PubMed ID: 20478877
[TBL] [Abstract][Full Text] [Related]
9. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
Lynch FL; Dickerson JF; Clarke G; Vitiello B; Porta G; Wagner KD; Emslie G; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes T; DeBar L; McCracken JT; Strober M; Suddath RL; Spirito A; Onorato M; Zelazny J; Iyengar S; Brent D
Arch Gen Psychiatry; 2011 Mar; 68(3):253-62. PubMed ID: 21383263
[TBL] [Abstract][Full Text] [Related]
10. Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.
Wagner KD; Asarnow JR; Vitiello B; Clarke G; Keller M; Emslie GJ; Ryan N; Porta G; Iyengar S; Ritz L; Zelanzny J; Onorato M; Brent D
J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):5-10. PubMed ID: 22251022
[TBL] [Abstract][Full Text] [Related]
11. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.
McMakin DL; Olino TM; Porta G; Dietz LJ; Emslie G; Clarke G; Wagner KD; Asarnow JR; Ryan ND; Birmaher B; Shamseddeen W; Mayes T; Kennard B; Spirito A; Keller M; Lynch FL; Dickerson JF; Brent DA
J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):404-11. PubMed ID: 22449646
[TBL] [Abstract][Full Text] [Related]
12. Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.
Bostic JQ
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1095-7. PubMed ID: 22023997
[No Abstract] [Full Text] [Related]
13. The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
Mansoor B; Rengasamy M; Hilton R; Porta G; He J; Spirito A; Emslie GJ; Mayes TL; Clarke G; Wagner KD; Shamseddeen W; Birmaher B; Ryan N; Brent D
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):458-67. PubMed ID: 24024532
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
15. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
Silverstone PH; Entsuah R; Hackett D
Int Clin Psychopharmacol; 2002 Nov; 17(6):273-80. PubMed ID: 12409680
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
17. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Strawn JR; Mills JA; Croarkin PE
J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
[No Abstract] [Full Text] [Related]
18. Substance use and the treatment of resistant depression in adolescents.
Goldstein BI; Shamseddeen W; Spirito A; Emslie G; Clarke G; Wagner KD; Asarnow JR; Vitiello B; Ryan N; Birmaher B; Mayes T; Onorato M; Zelazny J; Brent DA
J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1182-92. PubMed ID: 19858762
[TBL] [Abstract][Full Text] [Related]
19. What next? A Bayesian hierarchical modeling re-examination of treatments for adolescents with selective serotonin reuptake inhibitor-resistant depression.
Suresh V; Mills JA; Croarkin PE; Strawn JR
Depress Anxiety; 2020 Sep; 37(9):926-934. PubMed ID: 32579280
[TBL] [Abstract][Full Text] [Related]
20. Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.
Asarnow JR; Porta G; Spirito A; Emslie G; Clarke G; Wagner KD; Vitiello B; Keller M; Birmaher B; McCracken J; Mayes T; Berk M; Brent DA
J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):772-81. PubMed ID: 21784297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]